The E-cadherin-catenin complex in tumour metastasisstructure, function and regulation

European Journal of Cancer

Volumn 36, Issue 13, 2000, Pages 1607-1620

  Beavon, I R G ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Catenins; Cell adhesion; Cell signalling; E cadherin; Epidermal growth factor receptor; Growth factors; Hypoxia; Regulation; Tumour metastasis

Indexed keywords

ANGIOGENIC FACTOR; AUTOCRINE MOTILITY FACTOR; CATENIN; CELL ADHESION MOLECULE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; INTEGRIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN TYROSINE KINASE; TYROSINE AMINOTRANSFERASE; UVOMORULIN;

CELL ADHESION; CELL COMMUNICATION; CELL FUNCTION; HUMAN; HYPOXIA; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033853424     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00158-1     Document Type: Article

References (204)

1. Hart I.R., Saini A. Biology of tumour metastasis. Lancet. 339:1992;1453-1457.
2. Mareel M. De Baetselier P, Van Roy, F. Mechanisms of Invasion and Metastasis. 1991;Boca Raton, CRC Press.
3. Bernstein L.R., Liotta L.A. Molecular mediators of interactions with extracellular matrix components in metastasis and angiogenesis. Curr. Opin. Oncol. 6:1994;106-113.
4. Juliano R.L., Varner J.A. Adhesion molecules in cancer. the role of integrins Curr. Opin. Cell Biol. 5:1993;812-818.
5. Ellis V., Pike C., Erikson J., Solberg H., Danø K. The urokinase receptor. involvement in cell surface proteolysis and cancer invasion Ann. NY Acad. Sci. 667:1992;13-31.
6. Liotta L.A. Cancer cell invasion and metastasis. Sci. Am. 266:1992;34-41.
7. Matrisian L.M. The matrix-degrading metalloproteinases. Bioessays. 14:1992;455-463.
8. Stoker M., Gherardi E. Regulation of cell movement. the motogenic cytokines Biochim. Biophys. Acta. 1072:1991;81-102.
9. Van Roy F., Mareel M. Tumour invasion. effects of cell adhesion and motility Trends Cell Biol. 2:1992;163-169.
10. Nicolson G.L. Molecular mechanisms of cancer metastasis. tumor and host properties and the role of oncogenes and suppressor genes Curr. Opin. Oncol. 3:1991;75-92.
11. Baserga R. Oncogenes and the strategy of growth factors. Cell. 79:1994;927-930.
12. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1:1995;27-31.
13. Liotta L.A., Steeg P.S., Stetler-Stevenson W.G. Cancer metastasis and angiogenesis. an imbalance of positive and negative regulation Cell. 64:1991;327-336.
14. Birchmeier W., Beherens J. Cadherin expression in carcinomas. role in the formation of cell junctions and the prevention of invasiveness Biochim. Biophys. Acta. 1198:1994;11-26.
15. Mareel M., Bracke M., Van Roy F. Invasion promoter versus invasion suppressor molecules. the paradigm of E-cadherin Mol. Biol. Rep. 19:1994;45-67.
16. Takeishi M. Cadherins in cancer. implications for invasion and metastasis Curr. Opin. Cell Biol. 5:1993;806-811.
17. Shino Y., Watanabe A., Yamada Y.et al. Clinicopathologic evaluation of immunohistochemical E-cadherin expression in human gastric carcinomas. Cancer. 76:1995;2193-2201.
18. Tamura S., Shiozaki H., Miyata M.et al. Decreased E-cadherin expression is associated with haematogenous recurrence and poor prognosis in patients with squamous cell carcinoma of the oesophagus. Br. J. Surg. 83:1996;1608-1614.
19. Hunt N.C.A., Douglas-Jones A.G., Jasani B., Morgan J.M., Pignatelli M. Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas. Vichows Arch. 430:1997;285-289.
20. Bukholm I.K., Nesland J.M., Borresen-Dale A. Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not gamma-catenin, in metastatic tissue from breast cancer patients. J. Pathol. 190:2000;15-19.
21. Beavon I.R.G. Regulation of E-cadherin. does hypoxia initiate the metastatic cascade? J. Clin. Pathol. Mol. Pathol. 52:1999;179-188.
22. Le Bivic A., Sambuy Y., Mostov K., Rodriguez-Boulan E. Vectorial targeting of an endogenous apical membrane sialoglycoprotein and uvomorulin in MDCK cells. J. Cell Biol. 110:1990;1533-1539.
23. Lewis J.E., Jensen P.J., Johnson K.R., Wheelock M.J. E-cadherin mediates adherens junction organization through protein kinase C. J. Cell Sci. 108:1995;3615-3621.
24. Berx G., Staes K., van Hengel J.et al. Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics. 26:1995;281-289.
25. Mansouri A., Spurr N., Goodfellow P.N., Kemler R. Characterization and chromosomal localization of the gene encoding the human cell adhesion molecule uvomorulin. Differentiation. 38:1988;67-71.
26. Scherer G., Bausch E., Gaa A., von Deimling O. Gene mapping on mouse chromosome 8 by interspecific crosses. new data on a linkage group conserved on human chromosome 16q Genomics. 5:1989;275-278.
27. Ozawa M., Kemler R. Correct proteolytic cleavage is required for the cell adhesive function of uvomorulin. J. Cell Biol. 111:1990;1645-1650.
28. Overduin M., Harvey T.S., Bagby S.et al. Solution structure of the epithelial cadherin domain responsible for selective cell adhesion. Science. 267:1995;386-389.
29. Shapiro L., Fannon A.M., Kwong P.D.et al. Structural basis of cell-cell adhesion by cadherins. Nature. 374:1995;327-337.
30. Gallin W.J. Evolution of the 'classical' cadherin family of cell adhesion molecule in vertebrates. Mol. Biol. Evol. 15:1998;1099-1107.
31. Blaschuk O.W., Sullivan R., David S., Pouliot Y. Identification of a cadherin cell adhesion recognition sequence. Dev Biol. 139:1990;227-229.
32. 2+ dependence and mutational analysis reveal molecular details of E-cadherin homoassociation. EMBO J. 18:1999;1738-1747.
33. Nose A., Tsuji K., Takeichi M. Localization of specificity determining sites in cadherin cell adhesion molecules. Cell. 61:1990;147-155.
34. Ozawa M., Kemler R. The membrane proximal region of the E-cadherin cytoplasmic domain prevents dimerization and negatively regulates adhesion activity. J. Cell Biol. 142:1998;1605-1613.
35. Yap A.S., Brieher W.M., Pruschy M., Gumbiner B.M. Lateral clustering of the adhesive ectodomain. a fundamental determinant of cadherin function Curr Biol. 7:1997;308-315.
36. Katz B.Z., Levenberg S., Yamada K.M., Geiger B. Modulation of cell-cell adherens junctions by surface clustering of the N-cadherin cytoplasmic tail. Exp Cell Res. 243:1998;415-424.
37. Takeda H., Nagafuchi A., Yonemura S., Tsukita S., Behrens J., Birchmeier W. v-Src kinase shifts the cadherin-based cell adhesion from the strong to weak state and ß catenin is not required for the shift. J. Cell Biol. 131:1995;1839-1847.
38. Brieher W.M., Yap A.S., Gumbiner B.M. Lateral dimerization is required for the homophilic binding activity of C-cadherin. J. Cell Biol. 135:1996;487-496.
39. Angres B., Barth A., Nelson W.J. Mechanism for transition from initial to stable cell-cell adhesion. kinetic analysis of E-cadherin-mediated adhesion using a quantitative inhibition assay J. Cell Biol. 134:1996;549-557.
40. Adams C.L., Nelson W.J., Smith S.J. Quantitative analysis of cadherin-catenin-actin reorganization during development of cell-cell adhesion. J. Cell Biol. 135:1996;1899-1911.
41. Adams C.L., Nelson W.J. Cytomechanics of cadherin-mediated cell-cell adhesion. Curr. Opin. Cell Biol. 10:1998;572-577.
42. Provost E., Rimm D.L. Controversies at the cytoplasmic face of cadherin-based adhesion complex. Curr. Opin. Cell Biol. 11:1999;567-572.
43. Becker J.W., Erikson H.P., Hoffman S., Cunningham B.A., Edelman G.M. Topology of cell adhesion molecules. Proc. Natl. Acad. Sci. USA. 86:1989;1088-1092.
44. Ozawa M., Baribault H., Kemler R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J. 8:1989;1711-1717.
45. Ozawa M., Ringwald M., Kemler R. Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc. Natl. Acad. Sci. USA. 87:1990;4246-4250.
46. Herrenknecht K., Ozawa M., Eckerskorn C., Lottspeich F., Lenter M., Kemler R. The uvomorulin-anchorage protein alpha catenin is a vinculin homologue. Proc. Natl. Acad. Sci. USA. 88:1991;9156-9160.
47. McCrea P.D., Gumbiner B.M. Purification of a 92-kDa cytoplasmic protein tightly associated with the cell-cell adhesion molecule E-cadherin (uvomorulin). Characterization and extractability of the protein complex from the cell cytostructure. J. Biol. Chem. 266:1991;4514-4520.
48. Knudsen A.K., Wheelock M.J. Plakoglobin, or an 83-kD homologue distinct from beta-catenin, interacts with E-cadherin and N-cadherin. J. Cell Biol. 118:1992;671-679.
49. McPherson J.D., Morton R.A., Ewing C.M.et al. Assignment of the human alpha-catenin gene (CTNNA1) to chromosome 5q21-22. Genomics. 19:1994;188-190.
50. Kraus C., Liehr T., Hülsken J.et al. Localization of the human β-catenin gene (CTNNB1) to 3p21. a region implicated in tumor development Genomics. 23:1994;272-274.
51. Aberle H., Montagna M., Lynch H.T.et al. The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers. Proc. Natl. Acad. Sci. USA. 92:1995;6384-6388.
52. Reynolds A.B., Daniel J., McCrea P.D., Wheelock M.J., Wu J., Zhang Z. Identification of a new catenin. the tyrosine kinase substrate p120cas associates with E-cadherin complexes Mol. Cell Biol. 14:1994;8333-8342.
53. Reynolds A.B., Jenkins N.A., Gilbert D.J.et al. The gene encoding p120cas, a novel catenin, localizes on human chromosome 11q11 (CTNND) and mouse chromosome 2 (Catns). Genomics. 31:1996;127-129.
54. Shibamoto S., Hayakawa M., Taceuchi K.et al. Association of p120, a tyrosine kinase substrate, with E-cadherin/catenin complexes. J. Cell Biol. 128:1995;949-957.
55. Jou T.S., Stewart D.B., Stappert J., Nelson W.J., Marrs J.A. Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. Proc. Natl. Acad. Sci. USA. 92:1995;5067-5071.
56. Näthke I.S., Hinck L., Swedlow J.R., Papkoff J., Nelson W.J. Defining interactions and distributions of cadherin and catenin complexes in polarized epithelial cells. J. Cell Biol. 125:1994;1341-1352.
57. Hinck L., Näthke I.S., Papkoff J., Nelson W.J. Dynamics of cadherin/catenin complex formation. novel protein interactions and pathways of complex assembly J. Cell Biol. 125:1994;1327-1340.
58. Butz S., Kemler R. Distinct cadherin/catenin complexes in Ca (2+)-dependent cell-cell adhesion. FEBS Lett. 355:1994;195-200.
59. Nagafuchi A., Takeichi M. Transmembrane control of cadherin-mediated cell adhesion. a 94kDa protein functionally associated with a specific region of the cytoplasmic region of E-cadherin Cell Regul. 1:1990;37-44.
60. Aberle H., Butz S., Stappert J., Weissig H., Kemler R., Hoschuetzky H. Assembly of the cadherin-catenin complex in vitro with recombinant proteins. J. Cell Sci. 107:1994;3655-3663.
61. Lombardo C.R., Rimm D.L., Koslov E., Morrow J.S. Human recombinant alpha-catenin binds to spectrin. Mol. Biol. Cell. 5(Suppl.):1994;47. a.
62. Yap A.S., Niessen C.M., Gumbiner B.M. The juxtamembrane region of the cadherin cytoplasmic tail supports lateral clustering, adhesive strengthening, and interaction with p120ctn. J. Cell Biol. 141:1998;779-789.
63. Aono S., Nakagawa S., Reynolds A.B., Takeichi M. p120(ctn) acts as an inhibitory regulator of cadherin function in colon carcinoma cells. J. Cell Biol. 145:1999;551-562.
64. Reima I., Lehtonen E., Virtanen I., Flechon J.E. The cytoskeleton and associated proteins during cleavage, compaction and blastocyst differentiation in the pig. Differentiation. 54:1993;35-45.
65. Crossin K.L., Chuong C.M., Edelman G.M. Expression sequences of cell adhesion molecules. Proc. Natl. Acad. Sci. USA. 82:1985;6942-6946.
66. Whitlon D.S. E-cadherin in the mature and developing organ of Corti of the mouse. J. Neurocytol. 22:1993;1030-1038.
67. Van Aken J., Cuvelier C.A., De Wever N., Roels J., Gao Y., Mareel M.M. Immunohistochemical analysis of E-cadherin expression in human colorectal tumours. Pathol Res Pract. 189:1993;975-978.
68. Dorudi S., Sheffield J.P., Poulsom R., Northover J.M., Hart I.R. E-cadherin in colorectal cancer. An immunocytochemical and in situ hybridization study. Am. J. Pathol. 142:1993;981-986.
69. Yasui W., Kuniyasu H., Akama Y.et al. Expression of E-cadherin, alpha-, and beta-catenins in human gastric carcinomas. correlation with histology and tumor progression Oncology Reports. 2:1995;111-117.
70. Mayer B., Johnson J.P., Leitl F.et al. E-cadherin expression in primary and metastatic gastric cancer. down regulation correlates with cellular dedifferentiation and glandular disintegration Cancer Res. 53:1993;1690-1695.
71. Pignatelli M., Ansari T.W., Gunter P.et al. Loss of membranous E-cadherin expression in pancreatic cancer. correlation with lymph node metastasis, high grade, and advanced stage J. Pathol. 174:1994;243-248.
72. Kadowaki T., Shiozaki H., Inoue M.et al. E-cadherin and alpha-catenin expression in human esophageal cancer. Cancer Res. 54:1994;291-296.
73. Bongiorno P.F., al-Kasspooles M., Lee S.W.et al. E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus. Br. J. Cancer. 71:1995;166-172.
74. Slagle B.L., Zhou Y.Z., Birchmeier W., Scorsone K.A. Deletion of the E-cadherin gene in hepatitis B virus-positive Chinese hepatocellular carcinomas. Hepatology. 18:1993;757-762.
75. Bohm M., Totzeck B., Birchmeier W., Wieland I. Differences of E-cadherin expression levels and patterns of primary human lung cancer. Clin. Exp Metastasis. 12:1994;55-62.
76. Bringuier P.P., Umbas R., Schaafsma H.E., Karthaus H.F.M., Debryne F.M.J., Schalken J.A. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res. 53:1993;3241-3245.
77. Otto T., Birchmeier W., Schmidt U.et al. Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas. Cancer Res. 54:1994;3120-3123.
78. Dorkin T.J., Robson C.N., Neal D.E. The molecular pathology of urological malignancies. J. Pathol. 183:1997;380-387.
79. Morton R.A., Ewing C.M., Nagafuchi A., Tsukita S., Isaacs W.B. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells. Cancer Res. 53:1993;3585-3590.
80. Umbas R., Isaacs W.B., Bringuier P.P.et al. Decreased E-cadherin expression is associated with a poor prognosis in patients with prostate cancer. Cancer Res. 54:1994;3929-3933.
81. Otto T., Rembrink K., Goepel M., Meyer-Schwickerath M., Rubben H. E-cadherin. a marker for differentiation and invasiveness in prostatic carcinoma Urol Res. 21:1993;359-362.
82. Takayama T., Shiozaki H., Inoue M.et al. Expression of E-cadherin and alpha-catenin molecules in human breast cancer tissues and association with clinicopathological features. Int. J. Oncol. 5:1994;775-780.
83. Moll R., Mitze M., Frixen U.H., Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular carcinomas. Am. J. Pathol. 143:1993;1731-1742.
84. Palacios J., Benito N., Pizarro A.et al. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features. Am. J. Pathol. 146:1995;605-612.
85. Gamallo C., Palacios J., Suarez A.et al. Correlation of E-cadherin expression with differentiation grade and histological subtype in breast carcinoma. Am. J. Pathol. 142:1993;987-993.
86. Oka H., Shiozaki H., Kobayashi K.et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res. 53:1993;1696-1701.
87. Rasbridge S.A., Gillett C.E., Sampson S.A., Walsh F.S., Millis R.R. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J. Pathol. 169:1993;245-250.
88. De Leeuw W.J.F., Berx G., Vos C.B.J.et al. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J. Pathol. 183:1997;404-411.
89. Sakuragi N., Nishiya M., Ikeda K.et al. Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion. Gynecol Oncol. 53:1994;183-189.
90. Veatch A.L., Carson L.F., Ramakrishnan S. Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells. Int. J. Cancer. 58:1994;393-399.
91. Brabant G., Hoang-Vu C., Ceti Y.et al. E-cadherin. a differentiation marker in thyroid malignancies Cancer Res. 53:1993;4987-4993.
92. Pizarro A., Benito N., Navarro P.et al. E-cadherin expression in basal cell carcinoma. Br. J. Cancer. 69:1994;157-162.
93. Sakaki T., Wato M., Kaji R., Mushimoto K., Shirasu R., Tanaka A. Correlation of E- and P-cadherin expression with differentiation grade and mode of invasion in gingival carcinoma. Pathology. 44:1994;280-286.
94. Mattijssen V., Peters H.M., Schalkwijk L.et al. E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int. J. Cancer. 55:1993;580-585.
95. Nicholson L.J., Pei X.F., Watt F.M. Expression of E-cadherin, P-cadherin and involucrin by normal and neoplastic keratinocytes in culture. Carcinogenesis. 12:1991;1345-1349.
96. Andrews N.A., Jones A.S., Helliwell T.R., Kinsella A.R. Expression of the E-cadherin-catenin adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases. Br. J. Cancer. 75:1997;1474-1480.
97. Kawanishi J., Kato J., Sasaki K., Fujii S., Watanabe N., Niitsu Y. Loss of E-cadherin-dependent cell-cell adhesion due to maturation of the β-catenin gene in a human cancer cell line, HSC-39. Mol. Cell Biol. 15:1995;1175-1181.
98. Navarro P., Lozano E., Cano A. Expression of E- or P-cadherin is not sufficient to modify the morphology and tumorigenic behavior of murine spindle carcinoma cells. Possible involvement of plakoglobin. J. Cell Sci. 105:1993;923-934.
99. Oyama T., Kanai Y., Ochiai A.et al. A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin. a cause of loss of intercellular adhesiveness in human cancer cell lines Cancer Res. 54:1994;6282-6287.
100. Reise D.J.I., Stern D.F. Specificity within the EGF family/ErbB receptor family signaling network. Bioessays. 20:1998;41-48.
101. Hackel P.O., Zwick E., Prenzel N., Ullrich A. Epidermal growth factor receptors. critical mediators of multiple receptor pathways Curr. Opin. Cell Biol. 11:1999;184-189.
102. Shiozaki H., Kadowaki T., Doki Y.et al. Effect of epidermal growth factor on cadherin-mediated adhesion in a human oesophageal cancer cell line. Br. J. Cancer. 71:1995;250-258.
103. Shiozaki H., Oka H., Inoue M., Tamura S., Monden M. E-cadherin mediated adhesion system in cancer cells. Cancer. 77(Suppl.):1996;1605-1613.
104. Dogan A., Wang Z.D., Spencer J. E-cadherin expression in intestinal epithelium. J. Clin. Pathol. 48:1995;143-146.
105. Nabi I.R., Watanabe H., Raz A. Autocrine motility factor and its receptor. role in cell locomotion and metastasis Cancer Metastasis Rev. 11:1992;5-20.
106. Ruiz P., Günthert U. The cellular basis of metastasis. World J. Urol. 14:1996;141-150.
107. Boros P., Miller C.M. Hepatocyte growth factor. a multifunctional cytokine Lancet. 345:1995;293-295.
108. Birchmeier C., Birchmeier W. Molecular aspects of mesenchymal-epithelial interactions. Annu Rev Cell Biol. 9:1993;511-540.
109. Rosen E.M., Nigam S.K., Goldberg I.D. Scatter factor and the c-Met receptor. a paradigm for mesenchymal/epithelial interaction J. Cell Biol. 127:1994;1783-1787.
110. Stoker M., Gherardi E., Perryman M., Gray J. Scatter factor is a fibroblast-derived modulator of epithelial mobility. Nature. 327:1987;239-242.
111. Gherardi E., Gray J., Stoker M., Perryman M., Furlong R. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc. Natl. Acad. Sci. USA. 86:1989;5844-5848.
112. Nakamura T., Nishizawa T., Hagiya M.et al. Molecular cloning and expression of human hepatocyte growth factor. Nature. 342:1989;440-443.
113. Montesano R., Matsumoto K., Nakamura T., Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell. 67:1991;901-908.
114. Mackay D.J.G., Hall A. Rho GTPases. J. Biol. Chem. 273:1998;20685-20688.
115. Kuroda S., Fukata M., Nakagawa M.et al. Role of IQGAP1, a target of the small GTPases Cdc42 and Rac1, in the regulation of E-cadherin-mediated cell-cell adhesion. Science. 281:1998;832-835.
116. Braga V.M.M., Del Maschio A., Machesky L., Dejana E. Regulation of cadherin function by Rho and Rac. modulation by junction maturation and cellular context Mol. Biol. Cell. 10:1999;9-22.
117. Fukata M., Kuroda S., Nakagawa M.et al. Cdc42 and Rac1 regulate the interaction of IQGAP1 with β-catenin. J. Biol. Chem. 274:1999;26044-26050.
118. Braga V.M.M. Small GTPases and regulation of cadherin dependent cell-cell adhesion. J. Clin. Pathol. Mol. Pathol. 52:1999;197-202.
119. Takai Y., Sasaki T., Tanaka K., Nakanishi H. Rho as a regulator of the cytoskeleton. Trends Biochem Sci. 20:1995;227-231.
120. Bourne H.R., Sanders D.A., McCormick F. The GTPase superfamily. conserved structure and molecular mechanism Nature. 349:1991;117-127.
121. Kaibuchi K., Kuroda S., Fukata M., Nakagawa M. Regulation of cadherin-mediated cell-cell adhesion by the Rho family GTPases. Curr. Opin. Cell Biol. 11:1999;591-596.
122. Clark E.A., King W.G., Brugge J.S., Symons M., Hynes R.O. Integrin-mediated signals regulated by members of the rho family of GTPases. J. Cell Biol. 142:1998;573-586.
123. Gimond C., van Der Flier A., van Delft S.et al. Induction of cell scattering by expression of beta1 integrins in beta1-deficient epithelial cells requires activation of members of the rho family of GTPases and downregulation of cadherin and catenin function. J. Cell Biol. 147:1999;1325-1340.
124. Wojciak-Stothard B., Entwistle A., Garg R., Ridley A.J. Regulation of TNF-alpha-induced reorganization of the actin cytoskeleton and cell-cell junctions by Rho, Rac, and Cdc42 in human endothelial cells. J. Cell Physiol. 176:1998;150-165.
125. Tabibzadeh S., Kong Q.F., Kapur S., Satyaswaroop P.G., Aktories K. Tumour necrosis factor-alpha-mediated dyscohesion of epithelial cells is associated with disordered expression of cadherin/beta-catenin and disassembly of actin filaments. Human Reprod. 10:1995;994-1004.
126. Damsky C.H., Werb Z. Signal transduction by integrin receptors for extracellular matrix. cooperative processing of extracellular information Curr. Opin. Cell Biol. 4:1992;772-781.
127. Moon R.T., Brown J.D., Torres M. WNTs modulate cell fate and behavior during vertebrate development. Trends Genet. 13:1997;157-163.
128. Wang Y., Macke J.P., Abella B.S.et al. A large family of putative transmembrane receptors homologous to the product of the Drosophila tissue polarity gene frizzled. J. Biol. Chem. 271:1996;4468-4476.
129. Bhanot P., Brink M., Samos C.H.et al. A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature. 382:1996;225-230.
130. Yang-Snyder J., Miller J.R., Brown J.D., Lai C.J., Moon R.T. A frizzled homologue functions in vertebrate Wnt signaling pathway. Curr Biol. 6:1996;1302-1306.
131. Klingensmith J., Nusse R., Perrimon N. The Drosophila segment polarity gene dishevelled encodes a novel protein required for response to the wingless signal. Genes Dev. 8:1994;118-130.
132. Willert K., Brink M., Wodarz A., Varmus H., Nusse R. Casein kinase 2 associates with and phosphorylates dishevelled. EMBO J. 16:1997;3089-3096.
133. Cook D., Fry M.J., Hughes K., Sumathipala R., Woodgett J.R., Dale T.C. Wingless inactivates glycogen synthase kinase-3 via an intracellular signaling pathway which involves a protein kinase C. EMBO J. 15:1996;4526-4536.
134. Hart M.J., de los Santos R., Albert I., Rubinfeld B., Polakis P. Downregulation of β-catenin by human axin and its association with the APC tumor suppressor, β-catenin and GSK3β Curr Biol. 8:1998;573-581.
135. Behrens J., Jerchow B.A., Wurtele M.et al. Functional interaction of an axin homologue, conductin, with beta-catenin, APC and GSK3beta. Science. 280:1998;596-599.
136. Sakana C., Weiss J.B., Lewis L.T. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription. Proc. Natl. Acad. Sci. USA. 95:1998;3020-3023.
137. Dierick H., Besjovec A. Cellular mechanisms of wingless/Wnt signal transduction. Curr. Topics Dev. Biol. 43:1999;153-190.
138. Aberle H., Bauer A., Stappert J., Kispert A., Kemler R. Beta-catenin is a target for the ubiquitin-proteosome pathway. EMBO J. 16:1997;3797-3804.
139. Behrens J., von Kleis J.P., Kuhl M., Bruhn C., Wedlich D., Grosschedl R. Functional interaction of β-catenin with the transcription factor LEF-1. Nature. 382:1996;638-642.
140. Huber A.H., Nelson W.J., Weis W.I. Three-dimensional structure of armadillo repeat region of β-catenin. Cell. 90:1997;871-882.
141. Van de Wetering M., Cavallo R., Dooijes D.et al. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell. 88:1997;789-799.
142. Cavallo R., Rubenstein D., Peifer M. Armadillo and dTCF. a marriage made in the nucleus Curr. Opin. Genet. Dev. 7:1997;459-466.
143. He T.C., Sparks A.B., Rago C.et al. Identification of c-MYC as a target of the APC pathway. Science. 281:1998;1509-1512.
144. Shtutman M., Zhurinsky J., Simcha I.et al. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA. 96:1999;5522-5527.
145. Huber O., Bierkamp C., Kemler R. Cadherins and catenins in development. Curr. Opin. Cell Biol. 8:1998;685-691.
146. St Croix B., Sheehan C., Rak J.W., Florenes V.A., Slingerland J.M., Kerbel R.S. E-cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1). J. Cell Biol. 142:1998;557-571.
147. Yanagisawa K., Kosaka A., Iwahana H., Nakanishi M., Tominaga S. Opposite regulation of the expression of cyclin-dependent kinase inhibitors during contact inhibition. J. Biochem. 125:1999;36-40.
148. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature. 371:1994;257-261.
149. Navarro P., Ruco L., Dejana E. Differential location of VE- and N-cadherins in human endothelial cells. VE-cadherin competes with N-cadherin for junctional localization J. Cell Biol. 140:1998;1475-1484.
150. Steinberg M.S., McNutt P.M. Cadherins and their connections. adhesion junctions have broader functions Curr. Opin. Cell Biol. 11:1999;554-560.
151. c-src. Mol. Cell Biol. 8:1988;497-501.
152. ras-GTP and enhanced DNA synthesis accompany elevated tyrosyl phosphorylation of GAP-associated proteins, p190 and p62 in c-src overexpressors. Oncogene. 8:1993;959-967.
153. Jiang W.G. E-cadherin and its associated protein catenins, cancer invasion and metastasis. Br. J. Surg. 83:1996;437-446.
154. Damstrup L., Rude Voldborg B., Spang-Thomsen M., Brunner N., Skovgaard Poulsen H. In vitro invasion of small-cell lung cancer cell lines correlates with expression of epidermal growth factor receptor. Br. J. Cancer. 78:1998;631-640.
155. Almadori G., Cadoni G., Galli J.et al. Epidermal growth factor expression in primary laryngeal cancer. an independent prognostic factor neck node relapse Int. J. Cancer. 84:1999;188-191.
156. Chen B.K., Ohtsuki Y., Furihata M.et al. Co-overexpression of p53 protein and epidermal growth factor receptor in human papillary thyroid carcinomas correlated with lymph node metastasis, tumor size and clinicopathologic stage. Int. J. Oncol. 15:1999;893-898.
157. Gupta S.K., Douglas-Jones A.G., Jasani B., Morgan J.M., Pignatelli M., Mansel R.E. E-cadherin (E-cad) expression in duct carcinoma in situ (DCIS) of the breast. Virchows Arch. 430:1997;23-28.
158. Pilichowska M., Kimura N., Fujiwara H., Nagura H. Immunohistochemical study of TGF-α, TGF-β, EGFR, and IGF-1 expression in human breast carcinoma. Mod. Pathol. 10:1997;969-975.
159. Panico L., D'Antonio A., Salvatore G., Mezza E., Tortora G., De Laurentiis M.et al. Differential immunohistochemical detection of transforming growth factor α, amphiregulin, and CRIPTO in normal and malignant breast tissue. Int. J. Cancer. 65:1996;51-56.
160. Toropainen E., Lipponen P., Syrjanen K. Expression of insulin-like growth factor 1 (IGF-1) in female breast cancer as related to established prognostic factors and long-term prognosis. Eur. J. Cancer. 31:1995;1443-1448.
161. Sainsbury J.R.C., Hirst E.A., Needham G.K., Farndon J.R., Harris A.L. Fibroblast cell lines derived from human breast cancers have epidermal growth factor receptors and produce an epidermal growth factor-like molecule. Br. J. Cancer. 52:1985;440.
162. Powell S.M., Zilz N., Beazer-Barclay Y.et al. APC mutations occur early during colorectal tumorigenesis. Nature. 359:1992;235-237.
163. Bodmer W., Bishop T., Karran P. Genetic steps in colorectal cancer. Nature Genet. 6:1994;217-219.
164. Polakis P. Mutations in the APC gene and their implications for protein structure and function. Curr. Opin. Genet. Dev. 5:1995;66-71.
165. Näthke I.S. The adenomatous polyposis coli protein. J. Clin. Pathol. Mol. Pathol. 52:1999;169-173.
166. Munemitsu S., Albert I., Souza B., Rubinfeld B., Polakis P. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl. Acad. Sci. USA. 92:1995;3046-3050.
167. Stewart D.B., Nelson W.J. Identification of four distinct pools of catenins in mammalian cell and transformation-dependent changes in catenin distributions among these pools. J. Biol. Chem. 272:1997;29652-29662.
168. Smith M.E.F., Pignatelli M. The molecular histology of neoplasia. the role of the cadherin/catenin complex Histopathology. 31:1997;107-111.
169. Becker K.F., Atkinson M.J., Reich U.et al. Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas. Human Mol. Genetics. 2:1993;803-804.
170. Kanai Y., Oda T., Tsuda H., Ochiai A., Hirohashi S. Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast. Jpn. J. Cancer Res. 85:1994;1035-1039.
171. Risinger J.I., Berchuck A., Kohler M.F., Boyd J. Mutations of the E-cadherin gene in human gynecologic cancers. Nature Genet. 7:1994;98-102.
172. Berx G., Cleton-Jansen A.M., Stumane K.et al. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene. 13:1996;1919-1925.
173. Lishman S.C., Lakhani S.R. Atypical lobular hyperplasia and lobular carcinoma in situ. surgical and molecular pathology Histopathology. 35:1999;195-200.
174. Berx G., Nollet F., Van Roy F. Dysregulation of the E-cadherin/catenin complex by irreversible mutations in human carcinomas. Cell Adhes. Commun. 6:1998;171-184.
175. Guilford P., Hopkins J., Harraway J.et al. E-cadherin germline mutations in familial gastric cancer. Nature. 392:1998;402-405.
176. Gayther S.A., Gorringe K.L., Ramus S.J.et al. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res. 58:1998;4086-4089.
177. Guilford P. E-cadherin downregulation in cancer. fuel on fire? Mol. Med. Today. 5:1999;172-177.
178. Novak A., Hsu S.C., Leung-Hagesteijn C.et al. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and β-catenin signaling pathways. Proc. Natl. Acad. Sci. USA. 95:1998;4374-4379.
179. Shimoyama Y., Nagafuchi A., Fujita S.et al. Cadherin dysfunction in a human cancer cell line. possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness Cancer Res. 52:1992;5770-5774.
180. Oda T., Kanai Y., Shimoyama Y., Nagafuchi A., Tsukita S., Hirohashi S. Cloning of the human alpha-catenin cDNA and its aberrant mRNA in a human cancer cell line. Biochem. Biophys. Res. Commun. 193:1993;897-904.
181. 2+-dependant cell-cell adhesion. Cell Adhesion Commun. 1:1993;239-250.
182. Inoue M., Ogawa H., Miyata M., Shiozaki H., Tanizawa O. Expression of E-cadherin in normal, benign, and malignant tissues of female genital organs. Am. J. Clin. Pathol. 98:1992;76-80.
183. Ramesh S., Nash J., McCulloch P.G. Reduction in membranous expression of β-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer. Br. J. Cancer. 81:1999;1392-1397.
184. Hirvikoski P., Kumulainen E.J., Virtaniemi J.A.et al. Cytoplasmic accumulation of alpha-catenin is associated with aggressive features in laryngeal squamous-cell carcinoma. Int. J. Cancer. 79:1998;546-550.
185. Katayama M., Hirai S., Yasumoto M.et al. Soluble fragments of E-cadherin cell adhesion molecule increase in urinary excretion of cancer patients, potentially indicating its shedding from epithelial tumor cells. Int. J. Oncol. 5:1994;1049-1057.
186. Katayama M., Hirai S., Kamihagi K., Nakagawa K., Yasumoto M., Kato I. Soluble E-cadherin fragments increased in circulation of cancer patients. Br. J. Cancer. 69:1994;580-585.
187. Schuhmacher C., Becker K-F., Reich U.et al. Rapid detection of mutated E-cadherin in peritoneal lavage specimens from patients with diffuse-type gastric carcinoma. Diag. Mol. Pathol. 8:1999;66-70.
188. Banks R.E., Porter W.H., Whelan P., Smith P.H., Selby P.J. Soluble forms of the adhesion molecule E-cadherin in urine. J. Clin. Pathol. 48:1995;179-180.
189. Sundfor K., Lyng H., Rofstad E.K. Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. Br. J. Cancer. 78:1998;822-827.
190. Brizel D.M., Sibley G.S., Prosnitz L.R., Scher R.L., Dewhirst M.W. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int.
191. Brizel D.M., Scully S.P., Harrelson J.M.et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56:1996;941-943.
192. Ramsay J., Suit H.D., Sedlacek R. Experimental studies on the incidence of metastases after failure of radiation treatment and the effect of salvage surgery. Int. J. Radiat. Oncol. Biol. Phys. 14:1998;1165-1168.
193. Nathanson S.D., Westrick P., Anaya P.et al. Relationship of spontaneous regional lymph node metastases to dose of local irradiation of primary B16 melanomas. Cancer Res. 49:1989;4412-4416.
194. Shrieve D.C., Begg A.C. Cell cycle kinetics of aerated, hypoxic and re-aerated cells in vitro using flow cytometric determination of cellular DNA and incorporated bromodeoxyuridine. Cell Tissue Kinetics. 18:1985;641-651.
195. Rice G.C., Hoy C., Schimke R.T. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. USA. 83:1986;5978-5982.
196. Maiese K., Boniece I., DeMeo D.et al. Peptide growth factors protect against ischemia in culture by preventing nitric oxide toxicity. J. Neurosci. 13:1993;3034-3040.
197. Thomsen L.L., Miles D.W. Role of nitric oxide in tumour progression. lessons from human tumours Cancer Metastasis Rev. 17:1998;107-118.
198. Graham C.H., Forsdike J., Fitzgerald C.J., Macdonald-Goodfellow S. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int. J. Cancer. 80:1999;617-623.
199. Kunz M., Hartmann A., Flory E.et al. Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness. Am. J. Pathol. 155:1999;753-763.
200. Shi Q., Abbruzzese J.L., Huang S., Fidler I.J., Xiong Q., Xie K. Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Clin. Cancer Res. 5:1999;3711-3721.
201. Shi Q., Le X., Abbruzzese J.L.et al. Cooperation between transcription factor AP-1 and NF-kappaB in the induction of interleukin-8 in human pancreatic adenocarcinoma cells by hypoxia. J. Interferon Cytokine Res. 19:1999;1363-1371.
202. Zhong H., De Marzo A.M., Laughner E.et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 59:1999;5830-5835.
203. Garner A.P., Paine M.J., Rodriguez-Crespo I.et al. Nitric oxide synthases catalyse the activation of redox cycling and bioreductive anticancer agents. Cancer Res. 59:1999;1929-1934.
204. Wouters B.G., Wang L.H., Brown J.M. Tirapazamine. a new drug producing tumor specific enhancement of platinum-based chemotherapy in non-small-cell lung cancer Ann. Oncol. 5(Suppl.):1999;S29-S33.